Illinois Municipal Retirement Fund Grows Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Illinois Municipal Retirement Fund increased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 24.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,813 shares of the medical instruments supplier’s stock after purchasing an additional 2,517 shares during the period. Illinois Municipal Retirement Fund owned 0.05% of ICU Medical worth $1,988,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Equitable Trust Co. lifted its holdings in shares of ICU Medical by 1.6% in the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock worth $822,000 after buying an additional 84 shares in the last quarter. Allworth Financial LP lifted its stake in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Connable Office Inc. boosted its holdings in shares of ICU Medical by 6.4% during the 3rd quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock valued at $370,000 after purchasing an additional 122 shares during the last quarter. Gagnon Securities LLC grew its position in shares of ICU Medical by 0.5% during the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier’s stock valued at $4,481,000 after purchasing an additional 137 shares in the last quarter. Finally, Wealthspire Advisors LLC increased its holdings in shares of ICU Medical by 6.4% in the fourth quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier’s stock worth $413,000 after purchasing an additional 160 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 6.70% of the stock is currently owned by insiders.

ICU Medical Price Performance

NASDAQ:ICUI opened at $146.33 on Friday. The firm has a market capitalization of $3.58 billion, a price-to-earnings ratio of -32.02 and a beta of 0.63. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The business has a 50 day simple moving average of $160.42 and a 200-day simple moving average of $166.08. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26.

Analysts Set New Price Targets

A number of brokerages recently commented on ICUI. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. Finally, KeyCorp increased their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.